193 related articles for article (PubMed ID: 2704034)
1. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
Hsieh KH; LaHann TR; Speth RC
J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
[TBL] [Abstract][Full Text] [Related]
2. Effects of D-amino acid substitution on antagonist activities of angiotensin II analogues.
Samanen J; Narindray D; Adams W; Cash T; Yellin T; Regoli D
J Med Chem; 1988 Mar; 31(3):510-6. PubMed ID: 3346871
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for the carboxy-terminus truncated analogues of angiotension II, a new class of angiotensin II antagonists.
Bovy PR; O'Neal JM; Olins GM; Patton DR; McMahon EG; Palomo M; Koepke JP; Salles KS; Trapani AJ; Smits GJ
J Med Chem; 1990 May; 33(5):1477-82. PubMed ID: 2329570
[TBL] [Abstract][Full Text] [Related]
4. Conformational restriction of angiotensin II: cyclic analogues having high potency.
Spear KL; Brown MS; Reinhard EJ; McMahon EG; Olins GM; Palomo MA; Patton DR
J Med Chem; 1990 Jul; 33(7):1935-40. PubMed ID: 2362273
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
[TBL] [Abstract][Full Text] [Related]
6. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues.
Bennett JP; Snyder SH
Eur J Pharmacol; 1980 Oct; 67(1):11-25. PubMed ID: 6252019
[TBL] [Abstract][Full Text] [Related]
7. Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion.
Bennett JP; Snyder SH
Eur J Pharmacol; 1980 Oct; 67(1):1-10. PubMed ID: 6252018
[TBL] [Abstract][Full Text] [Related]
8. Long-acting angiotensin II inhibitors containing hexafluorovaline in position 8.
Hsieh KH; Needleman P; Marshall GR
J Med Chem; 1987 Jun; 30(6):1097-100. PubMed ID: 3585907
[TBL] [Abstract][Full Text] [Related]
9. Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole.
Moore GJ; Ganter RC; Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Wilkinson S; Sandall J; Fowler P
J Mol Recognit; 1994 Dec; 7(4):251-6. PubMed ID: 7734150
[TBL] [Abstract][Full Text] [Related]
10. The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.
Duncia JV; Chiu AT; Carini DJ; Gregory GB; Johnson AL; Price WA; Wells GJ; Wong PC; Calabrese JC; Timmermans PB
J Med Chem; 1990 May; 33(5):1312-29. PubMed ID: 2329553
[TBL] [Abstract][Full Text] [Related]
11. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
[TBL] [Abstract][Full Text] [Related]
12. AT1 receptor characteristics of angiotensin analogue binding in human synovium.
Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J
Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
Robberecht W; Andries M; Denef C
Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal modulation of the binding of angiotensin agonists and antagonists to angiotensin receptors in smooth muscle.
Koziarz P; Beck J; Moore GJ
Gen Pharmacol; 1993 May; 24(3):705-13. PubMed ID: 8365653
[TBL] [Abstract][Full Text] [Related]
15. Quantitative autoradiography of 125I-[Sar1, Ile8]-angiotensin II binding in the brain of spontaneously hypertensive rats.
Hwang BH; Harding JW; Liu DK; Hibbard LS; Wieczorek CM; Wu JY
Brain Res Bull; 1986 Jan; 16(1):75-82. PubMed ID: 3006878
[TBL] [Abstract][Full Text] [Related]
16. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
Moore GJ; Ganter RC; Goghari MH; Franklin KJ
Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the pressor response to angiotensins I and II in the bullfrog, Rana catesbeiana.
Harper RA; Stephens GA
Gen Comp Endocrinol; 1985 Nov; 60(2):227-35. PubMed ID: 3905501
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization of photoaffinity-labeled angiotensin II receptors.
Carson MC; Harper CM; Baukal AJ; Aguilera G; Catt KJ
Mol Endocrinol; 1987 Feb; 1(2):147-53. PubMed ID: 3137454
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptors labelled with 125I-[Sar1, Ile8]-AII in albino rabbit ocular tissues.
Mallorga P; Babilon RW; Sugrue MF
Curr Eye Res; 1989 Aug; 8(8):841-9. PubMed ID: 2791629
[TBL] [Abstract][Full Text] [Related]
20. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
